| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9779 | 
      | Human Intestinal Absorption | HIA+ | 0.9804 | 
      | Caco-2 Permeability | Caco2+ | 0.5727 | 
      | P-glycoprotein Substrate | Substrate | 0.8336 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.8969 | 
                                                     | Inhibitor | 0.7848 | 
      | Renal Organic Cation Transporter | Inhibitor | 0.5989 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.4704 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7619 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.6056 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5126 | 
      | CYP450 1A2 Inhibitor | Inhibitor | 0.7497 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.6261 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.7317 | 
      | CYP450 2C19 Inhibitor | Inhibitor | 0.6870 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.6222 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8952 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8844 | 
                                                                    | Inhibitor | 0.6767 | 
      | AMES Toxicity | Non AMES toxic | 0.8060 | 
      | Carcinogens | Non-carcinogens | 0.9161 | 
      | Fish Toxicity | High FHMT | 0.9717 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9871 | 
      | Honey Bee Toxicity | Low HBT | 0.8482 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | II | 0.4787 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6260 |